Figures & data
Table 1 Baseline patient characteristics
Figure 1 IOP over time.
Abbreviations: IOP, intraocular pressure; LAT, latanoprost; UNO, unoprostone.
![Figure 1 IOP over time.](/cms/asset/470829b7-7068-4aec-873f-571165dc1fa6/doph_a_144344_f0001_b.jpg)
Figure 2 Survival curve of visual field nonprogression.
Abbreviations: LAT, latanoprost; MD, mean deviation; PSD, pattern standard deviation; TD, total deviation; UNO, unoprostone.
![Figure 2 Survival curve of visual field nonprogression.](/cms/asset/f7bb5b4c-119a-4ad7-a7c9-10be9daf72f3/doph_a_144344_f0002_b.jpg)
Figure 3 Survival curve of visual field nonprogression in GPA.
Abbreviations: GPA, guided progression analysis; LAT, latanoprost; UNO, unoprostone.
![Figure 3 Survival curve of visual field nonprogression in GPA.](/cms/asset/da9e81c7-11d1-4865-ad28-0225a5066d41/doph_a_144344_f0003_b.jpg)
Table 2 Analysis of the rate of nonprogression of visual field loss
Table 3 HRT-II changes
Table 4 Patient dropouts